COMMUNIQUÉS West-GlobeNewswire

Ochsner Health System and Vital Images® Announce New Partnership
15/01/2018
NEW ORLEANS, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Ochsner Health System and Vital Images announced today a partnership to deploy an enterprise imaging solution that will support Ochsner and its vision of a [...]
MPI's spinout Oncology Venture will execute license to multi TKI phase 3 compound
15/01/2018
Hoersholm, Denmark, January 15, 2018 - Medical Prognosis Institute A/S (MPI.ST) spinout Oncology Venture AB (OV:ST) announces: As previously announced to the market on December 14, 2017, Oncology Venture hereby disclose [...]
Scythian Biosciences Announces CEOs of Both Aphria and Liberty Health Sciences are Joining its Board
15/01/2018
TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that Mr. Vic Neufeld and Mr. George Scorsis, the [...]
Canada’s Leading Cannabis Health Care Service Signs First-of-its-kind Agreement with Durham College
15/01/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , on behalf of [...]
Extendicare Announces January 2018 Dividend of C$0.04 per Share
15/01/2018
MARKHAM, Ontario, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
REPEAT: Cannabis Wheaton Income Corp. Launches Kolab Project
15/01/2018
VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is excited to launch KoLab Project Inc. (“ KoLab [...]
Renaissance BioScience Corp. Retains Blair Jordan as Capital Markets Advisor
15/01/2018
VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp., a leading global yeast technology company, is pleased to announce that it has strengthened its capital markets team with the [...]
MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products
15/01/2018
TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) today announced that further to its press release dated August 22, 2017, it has entered into a [...]
Avivagen Announces Positive Results from Swine Trial
15/01/2018
OTTAWA, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the [...]
Cytovance® Biologics Welcomes Edwin Miranda as Vice President of Quality
15/01/2018
OKLAHOMA CITY, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces and welcomes Edwin Miranda as [...]
Xbrane Biopharma clarifies information regarding letter of intent with CR Pharma considering Xlucane
15/01/2018
Press release 2018-01-15 Xbrane Biopharma ("Xbrane" or the "Company") signed the 7 th of December 2017 a non-binding letter of intent with the Chinese pharmaceutical company CR Pharma regarding out-licensing of Xlucane [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
15/01/2018
FIT Biotech Oy Company release January 15, 2018 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm
15/01/2018
Press Release 15 January 2018 Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm Immunicum AB (publ), a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid [...]
Shire granted EU marketing authorization for ADYNOVI® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A
15/01/2018
Shire granted EU marketing authorization for ADYNOVI ® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A Marketing Authorization will enable patient access to ADYNOVI [...]
TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601
15/01/2018
PRESS RELEASE TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601 Leuven (BELGIUM) - January 15, 2018, 07:00 CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG [...]
TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l'essai de phase III ADMIRE-CD du Cx601
15/01/2018
COMMUNIQUÉ DE PRESSE TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l'essai de phase III ADMIRE-CD du Cx601 Louvain (BELGIQUE) - 15 janvier 2018, 07h. CET - TiGenix NV (Euronext [...]
Cannabis Wheaton Income Corp. Launches Kolab Project
15/01/2018
VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is excited to launch KoLab Project Inc. (“ KoLab [...]
Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives
15/01/2018
MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic [...]
Nova Leap Health Corp. Grants Stock Options
12/01/2018
HALIFAX, Novia Scotia, Jan. 12, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or the "Company"), a company focused on the home health care industry, has granted 1,485,000 incentive stock [...]

Pages